# Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer

> **NCT00226746** · PHASE2 · WITHDRAWN · sponsor: **New York Presbyterian Brooklyn Methodist Hospital**

## Conditions studied

- Carcinoma, Pancreatic Ductal

## Interventions

- **DRUG:** Paclitaxel and gemcitabine

## Key facts

- **NCT ID:** NCT00226746
- **Lead sponsor:** New York Presbyterian Brooklyn Methodist Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2003-03
- **Primary completion:** 2010-06
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00226746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00226746, "Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00226746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*